X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10) 10
humans (8) 8
male (8) 8
female (7) 7
middle aged (7) 7
aged (5) 5
cancer (5) 5
lung cancer (5) 5
survival (5) 5
adult (4) 4
care and treatment (4) 4
chemotherapy (4) 4
lung cancer, non-small cell (4) 4
medicine, general & internal (4) 4
metastasis (4) 4
oncology (4) 4
aged, 80 and over (3) 3
analysis (3) 3
hematology, oncology and palliative medicine (3) 3
lung neoplasms - drug therapy (3) 3
motivation (3) 3
mutation (3) 3
toxicity (3) 3
abridged index medicus (2) 2
bevacizumab (2) 2
brain neoplasms - secondary (2) 2
cancer therapies (2) 2
carcinoma, non-small-cell lung - drug therapy (2) 2
carcinoma, non-small-cell lung - genetics (2) 2
cell survival (2) 2
cisplatin (2) 2
clinical trials (2) 2
college teachers (2) 2
crizotinib (2) 2
epidermal growth factor receptors (2) 2
gefitinib (2) 2
gene (2) 2
interactive systems (2) 2
internal medicine (2) 2
kinases (2) 2
lung neoplasms - genetics (2) 2
lung neoplasms - pathology (2) 2
magnetic resonance imaging (2) 2
medical colleges (2) 2
metastases (2) 2
oncology, experimental (2) 2
patients (2) 2
pharmaceuticals (2) 2
platinum (2) 2
product development (2) 2
prognosis (2) 2
recruitment (2) 2
research (2) 2
respiratory agents (2) 2
risk (2) 2
risk factors (2) 2
treatment outcome (2) 2
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - genetics (1) 1
adenocarcinoma - metabolism (1) 1
adenocarcinoma - pathology (1) 1
adenocarcinoma - radiotherapy (1) 1
adenocarcinoma - secondary (1) 1
advanced nsclc (1) 1
af-001jp (1) 1
anaplastic lymphoma (1) 1
anaplastic lymphoma kinase (1) 1
angina (1) 1
angina, stable - epidemiology (1) 1
anorexia (1) 1
anti-infective agents - administration & dosage (1) 1
anti-infective agents - adverse effects (1) 1
anti-inflammatory agents, non-steroidal - administration & dosage (1) 1
antibiotic prophylaxis - methods (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
apoptosis (1) 1
articles (1) 1
asymptomatic brain metastases (1) 1
audio frequencies (1) 1
bayesian analysis (1) 1
bevacizumab - therapeutic use (1) 1
biomarkers - metabolism (1) 1
bleomycin hamster model (1) 1
brain - diagnostic imaging (1) 1
brain - pathology (1) 1
brain - surgery (1) 1
brain metastasis (1) 1
brain neoplasms - diagnostic imaging (1) 1
brain neoplasms - pathology (1) 1
brain neoplasms - prevention & control (1) 1
brain neoplasms - radiotherapy (1) 1
brain research (1) 1
c-met (1) 1
cancer patients (1) 1
carbazoles - pharmacokinetics (1) 1
carbazoles - therapeutic use (1) 1
carbon monoxide - metabolism (1) 1
carboplatin (1) 1
carcinoma, large cell - drug therapy (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2017, Volume 390, Issue 10089, pp. 29 - 39
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 2, pp. 121 - 128
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 7, pp. 590 - 598
Summary Background Currently, crizotinib is the only drug that has been approved for treatment of ALK -rearranged non-small-cell lung cancer (NSCLC). We aimed... 
Hematology, Oncology and Palliative Medicine | FUSION | GENE | ONCOLOGY | C-MET | KINASE | CRIZOTINIB | ANAPLASTIC LYMPHOMA | INHIBITOR | ROS1 | Carcinoma, Large Cell - drug therapy | Lung Neoplasms - drug therapy | Prognosis | Follow-Up Studies | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Humans | Lung Neoplasms - metabolism | Middle Aged | Male | Immunoenzyme Techniques | Adenocarcinoma - metabolism | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Piperidines - pharmacokinetics | Adenocarcinoma - genetics | Carcinoma, Large Cell - genetics | Lung Neoplasms - genetics | Protein Kinase Inhibitors - pharmacokinetics | Carcinoma, Large Cell - metabolism | Carcinoma, Non-Small-Cell Lung - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Receptor Protein-Tyrosine Kinases - metabolism | Adenocarcinoma - drug therapy | Maximum Tolerated Dose | Carcinoma, Squamous Cell - drug therapy | Receptor Protein-Tyrosine Kinases - genetics | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Gene Rearrangement | Carbazoles - pharmacokinetics | Aged | Carbazoles - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Care and treatment | Oncology, Experimental | Research | College teachers | Lung cancer, Non-small cell | Drug approval | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 5, pp. 663 - 671
Journal Article
by Mok, Tony and Mok, Tony S K and Wu, Yilong and Wu, Yi-Long and Kudaba, Iveta and Kowalski, Dariusz M and Kowalski, Dariusz and Cho, Byoung Chul and Turna, Hande and Turna, Hande Z and Castro, Hugo and Castro, Gilberto and Srimuninnimit, Vichien and Laktionov, Konstantin and Laktionov, Konstantin K and Bondarenko, Igor and Kubota, Kaoru and Lubiniecki, Gregory M and Zhang, Jin and Zhang, Li and Zhang, Xin and Kush, Debra and Lopes, Valeria and Lopes, Gilberto and Adamchuk, Grigory and Ahn, Myung-Ju and Alexandru, Aurelia and Altundag, Ozden and Alyasova, Anna and Andrusenko, Orest and Aoe, Keisuke and Araujo, Antonio and Aren, Osvaldo and Arrieta Rodriguez, Oscar and Ativitavas, Touch and Avendano, Oscar and Barata, Fernando and Barrios, Carlos Henrique and Beato, Carlos and Bergstrom, Per and Betticher, Daniel and Bolotina, Larisa and Botha, Michiel and Buddu, Sayeuri and Caglevic, Christian and Cardona, Andres and Cay Senler, Filiz and Cerny, Carlos Alexandre Sydow and Cesas, Alvydas and Chan, Gee-Chen and Chang, Jianhua and Chen, Xi and Chen, Gongyan and Cheng, Ying and Cheng, Susanna and Cherciu, Nelly and Chiu, Chao-Hua and Cicenas, Saulius and Ciurescu, Daniel and Cohen, Graham and Costa, Marcos Andre and Danchaivijitr, Pongwut and De Angelis, Flavia and de Azevedo, Sergio Jobim and Dediu, Mircea and Deliverski, Tsvetan and De Marchi, Pedro Rafael Martins and de The Bustamante Valles, Flor and Ding, Zhenyu and Doganov, Boyan and Dreosti, Lydia and Duarte, Ricardo and Edusma-Dy, Regina and Emelyanov, Sergey and Erman, Mustafa and Fan, Yun and Fein, Luis and Feng, Jifeng and Fenton, David and Fernandes, Gustavo and Ferreira, Carlos and Franke, Fabio Andre and Freitas, Helano and Fujisaka, Yasuhito and Galindo, Hector and Galvez, Christina and Ganea, Doina and Gil, Nuno and Girotto, Gustavo and Goker, Erdem and Goksel, Tuncay and Gomez Aubin, Gonzalo and Gomez Wolff, Luis and Griph, Hakan and Gumus, Mahmut and Hall, Jacqueline and Hart, Gregory and Havel, Libor and He, Yong and He, Jianxing and ... and KEYNOTE-042 Investigators
The Lancet, ISSN 0140-6736, 05/2019, Volume 393, Issue 10183, pp. 1819 - 1830
Journal Article
Journal of Diabetes Investigation, ISSN 2040-1116, 09/2017, Volume 8, Issue 5, pp. 677 - 686
Journal Article
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.